References
- EkedahlCManssonISandbergNSwallowing dysfunction in the brain-damaged with droolingActa Otolaryngol1974781–21411494416004
- Van De HeyningPHMarquetJFCretenWLDrooling in children with cerebral palsyActa Otorhinolaryngol Belg19803466917057223419
- ParkesJHillNPlattMJDonnellyCOromotor dysfunction and communication impairments in children with cerebral palsy: a register studyDev Med Child Neurol201052121113111920813020
- SennerJELogemannJZeckerSGaebler-SpiraDDrooling, saliva production, and swallowing in cerebral palsyDev Med Child Neurol2004461280180615581152
- ThomasKCNew drug bulletin: glycopyrrolate oral lolution (Cuvposa™ Shinongi Pharma, Inc)Salt Lake City, UTDepartment of Pharmacy Services, University of Utah Hospitals & Clinics2011
- Robinul (glyropyrrolate) [package insert]Deerfield, ILBaxter Healthcare Corporation2007
- Cuvposa™ (glycopyrrolate) solution [package insert]Florham Park, NJShionogi Pharma, Inc2010
- CoberMPJohnsonCESudekumDPenpraseKStability of extemporaneously prepared glycopyrrolate oral suspensionsAm J Health Syst Pharm201168984384521515869
- CavanaughKParkAPostparotidectomy fistula: a different treatment for an old problemInt J Pediatr Otorhinolaryngol199947326526810321782
- DuggalHSGlycopyrrolate for clozapine-induced sialorrheaProg Neuropsychopharmacol Biol Psychiatry20073171546154717614181
- BlascoPAManagement of drooling: 10 years after the Consortium on Drooling, 1990Dev Med Child Neurol2002441177878112418620
- TschengDZSialorrhea – therapeutic drug optionsAnn Pharmacother200236111785179012398577
- BachrachSJWalterRSTrzcinskiKUse of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsyClin Pediatr (Phila)19983784854909729704
- JongeriusPHJoostenFHoogenFJGabreelsFJRotteveelJJThe treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glandsLaryngoscope2003113110711112514392
- BlascoPAStansburyJCGlycopyrrolate treatment of chronic droolingArch Pediatr Adolesc Med199615099329358790123
- SternLMPreliminary study of glycopyrrolate in the management of droolingJ Paediatr Child Health199733152549069045
- BachrachSWalterRTrzcinskiKThe use of glycopyrrolate for drooling in children with cerebral palsyDev Med Child Neurol19953713:s7310
- WalkerSJWSummary review for regulatory action: Federal Drug Administration (FDA) Available at: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022571Orig1s000SumR.pdf. Accessed on September 12, 2011.
- MierRJBachrachSJLakinRCBarkerTChildsJMoranMTreatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging studyArch Pediatr Adolesc Med2000154121214121811115305
- ParrJRBuswellCABanerjeeKManagement of drooling in children: a survey of UK paediatricians’ clinical practiceChild Care Health Dev2011 [Epub ahead of print.]10.1111/j.1365-2214.2011.01213.x
- Thomas-StonellNGreenbergJThree treatment approaches and clinical factors in the reduction of droolingDysphagia19883273783271655
- Camp-BrunoJAWinsbergBGGreen-ParsonsARAbramsJPEfficacy of benztropine therapy for droolingDev Med Child Neurol19893133093192666205
- FairhurstCBCockerillHManagement of drooling in childrenArch Dis Child Educ Pract Ed2011961253020675519
- ReidSMJohnsonHMReddihoughDSThe Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilitiesDev Med Child Neurol2010522e23e2819843155